Lobbying Filing Details

Total Spending

$0

Activities

1

Lobbyists

1

Gov't Entities

3

Filing Information
Filing UUID:
4a7e946e-bc1d-4b9d-8cd7-3ac0bade9579
Type:
Q1 - 1st Quarter - Report
Period:
2023 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
May 04, 2023 at 7:00 PM
Income:
$0
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Burt Rosen
Registrant
BURT ROSEN STRATEGIES

Government Affairs Strategies and Advice

Washington, District of Columbia
Client
ATEA PHARMACEUTICALS

Drug development and COVID 19 issues involving FDA, DOD, HHS, and OWS

Massachusetts, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Issues specifically related to Covid drug development.

Lobbyists (1)
  • BURT ROSEN
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 5, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.